FindTrial
Sign In

Serum Myoglobin after Cardiac Surgery and 14-Day Mortality

Serum Myoglobin after Cardiac Surgery and short-term outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091732
Enrollment
Unknown
Registered
2024-11-01
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac disease

Interventions

Aortic surgery group:none
Other cardiac surgery group:none

Sponsors

The First Affiliated Hospital,Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.aged >=18 years old; 2.underwent cardiopulmonary bypass cardiac surgery;

Exclusion criteria

Exclusion criteria: 1.had preoperative renal dysfunction, defined as serum creatine before surgery greater than 176 µmol/L or a requirement for renal replacement therapy; 2.had preoperative acute heart failure(AHF) and acute myocardial infraction(AMI); 3.died in 24h after operation; 4.incomplete medical records;

Design outcomes

Primary

MeasureTime frame
Death within 14 days after operation;—

Secondary

MeasureTime frame
Complications within 14 days after operation;—

Countries

China

Contacts

Public ContactOu Jingsong

The First Affiliated Hospital, Sun Yat-sen University

oujs@mail.sysu.edu.cn+86 13631462338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026